Evaluation of the Quantra QStat System in Obstetric Patients
NCT05875987 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 50
Last updated 2024-05-13
Summary
This pilot study will assess the performance of the Quantra System with the QStat Cartridge versus standard of care coagulation testing in bleeding pregnant women at delivery.
Conditions
- Blood Loss Massive
- Post Operative Hemorrhage
Interventions
- DEVICE
-
Quantra System
Diagnostic device to monitor coagulation properties of a whole blood sample at the point-of-care.
Sponsors & Collaborators
-
HemoSonics LLC
lead INDUSTRY
Eligibility
- Min Age
- 18 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-06-01
- Primary Completion
- 2024-03-31
- Completion
- 2024-05-10
- FDA Device
- Yes
Countries
- United States
Study Locations
More Related Trials
-
High Risk Multiple Gestation Study
NCT02278874 ·Status: COMPLETED
-
Safety and Effectiveness of the Jada System in Treating Primary Postpartum Hemorrhage
NCT02883673 ·Status: COMPLETED ·Phase: NA
-
Clinical Performance of NIPT in Multiple Gestation Pregnancies
NCT04488393 ·Status: COMPLETED
-
Collection of Whole Blood Specimens in Pregnant Women
NCT03590678 ·Status: COMPLETED
-
Moderna COVID-19 Vaccine mRNA-1273 Observational Pregnancy Outcome Study
NCT04958304 ·Status: TERMINATED
-
Pregnancy and Fibrin Clot Properties
NCT07275476 ·Status: RECRUITING
-
Development of Non-invasive Prenatal Screening Test for Microdeletions Based on Fetal DNA Isolated From Maternal Blood
NCT01852708 ·Status: COMPLETED
-
Technical Feasibility of the cfDNA Test for Non-invasive Cytogenetic Analysis of Early Miscarriages Versus the Gold Standard Microarray
NCT05900076 ·Status: COMPLETED
-
Multiple Gestation Study
NCT02278536 ·Status: COMPLETED
-
Evaluation of Coagulation Status of Pregnant Women in the Peripartum Period Using the Device Clotpro®
NCT05935137 ·Status: COMPLETED
-
Cell Based Non Invasive Prenatal Testing as an Alternative to Chorionic Villus Sampling Following Preimplantation Genetic Testing
NCT04584047 ·Status: COMPLETED ·Phase: NA
-
The Use of Quantitative Pregnancy Test in Amniotic Fluid as a Diagnostic Tool for Rupture of Fetal Membranes
NCT03106311 ·Status: COMPLETED ·Phase: NA
-
THROmbinography in Pregnant Woman and in Vitro Action of Low Molecular Weight HEparin
NCT06575309 ·Status: RECRUITING
-
Non-invasive Prenatal Diagnostic Validation Study
NCT01574781 ·Status: COMPLETED
-
Towards Better Prognostic and Diagnostic Strategies for Haemostatic Changes During Major Obstetric Haemorrhage
NCT02149472 ·Status: COMPLETED
-
Covid-19 Infection in Pregnancy
NCT04869202 ·Status: COMPLETED
-
State of Coagulation in Pre-eclampsia: Comparing Sonoclot Signature Analysis With Conventional and Specific Haemostasis Assays
NCT05625763 ·Status: UNKNOWN
-
Pulmonary Embolism in Pregnancy: Biomarkers and Clinical Predictive Models
NCT02709174 ·Status: COMPLETED
-
Pregnancy and Risk of Venous Thromboembolism
NCT03659708 ·Status: RECRUITING ·Phase: NA
-
LMWH Compliance in Pregnancy
NCT05066867 ·Status: UNKNOWN
-
Efficacy Evaluation of Using Finger Stick Peripheral Blood for Point of Care Pregnancy Testing
NCT06747598 ·Status: COMPLETED
-
Progesterone for the Prevention of Miscarriage and Preterm Birth in Women With First Trimester Bleeding: PREEMPT Trial
NCT02145767 ·Status: COMPLETED ·Phase: PHASE2
-
Low Molecular Weight Heparin in Pregnancies With Unexplained Stillbirths
NCT03601338 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Effectiveness of Pregnancy Tests as an Assessment Tool to Identify Continuing Pregnancy
NCT01856777 ·Status: COMPLETED ·Phase: NA
-
PRospective Evaluation of Peripartum Anticoagulation ManaGement for ThrOmboembolism
NCT05756244 ·Status: RECRUITING